MedPath
NMPA Approval

Compound Sulfadiazine Tablets

国药准字H21020772

August 26, 2020

Drug Information

复方磺胺嘧啶片

片剂

磺胺嘧啶0.4g;甲氧苄啶50mg

化学药品

August 26, 2020

Company Information

Applicant Company

Manufacturing Company

丹东市振兴区浪头镇顺天545号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

复方磺胺嘧啶片 - NMPA 批准文号 | MedPath